{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:59:09Z","timestamp":1775195949094,"version":"3.50.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2025.e00816","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:00:18Z","timestamp":1765594818000},"page":"e00816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-dose combination of ultramicronized palmitoylethanolamide and docosahexaenoic acid on neurosteroid and neuroinflammatory dysregulation in autism spectrum disorders"],"prefix":"10.1016","volume":"23","author":[{"given":"Fabiana","family":"Filogamo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio Maria","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"La Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2025.e00816_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pnpbp.2013.09.005","article-title":"Multifunctional aspects of allopregnanolone in stress and related disorders","volume":"48","author":"Bali","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4753","key":"10.1016\/j.neurot.2025.e00816_bib2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.2422758","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor","volume":"232","author":"Majewska","year":"1986","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00816_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tips.2016.04.003","article-title":"Clinical potential of neurosteroids for CNS disorders","volume":"37","author":"Reddy","year":"2016","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00816_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10571-018-0618-1","article-title":"Allopregnanolone and progesterone in experimental neuropathic pain: former and new insights with a translational perspective","volume":"39","author":"Gonz\u00e1lez","year":"2019","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00816_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0006-8993(00)02373-8","article-title":"Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3\u03b1-hydroxy-5\u03b1-pregnan-20-one in mice11Published on the world wide web on 20 April 2000","volume":"865","author":"Khisti","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.neurot.2025.e00816_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neuroscience.2025.05.022","article-title":"Neurosteroids as emerging therapeutics for treatment-resistant depression: mechanisms and clinical potential","volume":"577","author":"Nagpurkar","year":"2025","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00816_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1212\/WNL.0000000000000623","article-title":"Allopregnanolone levels and seizure frequency in progesterone-treated women with epilepsy","volume":"83","author":"Herzog","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00816_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrendo.2013.31","article-title":"Neurosteroids as regenerative agents in the brain: therapeutic implications","volume":"9","author":"Brinton","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00816_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128313","article-title":"Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for alzheimer's disease. Stutzmann GE, curatore","volume":"10","author":"Irwin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00816_bib10","article-title":"Allopregnanolone and neuroinflammation: a focus on multiple sclerosis","author":"Noorbakhsh","year":"20148134","journal-title":". Front Cell Neurosci [Internet]"},{"key":"10.1016\/j.neurot.2025.e00816_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106766","article-title":"Therapeutic potential of enzymes, neurosteroids, and synthetic steroids in neurodegenerative disorders: a critical review","volume":"251","author":"Servi","year":"2025","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00816_bib12","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1073\/pnas.1001422107","article-title":"Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neurot.2025.e00816_bib13","series-title":"Diagnostic and statistical manual of mental disorders","year":"2000"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00816_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00816_bib15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/brainsci12040460","article-title":"Altered cytokine and BDNF levels in individuals with autism spectrum disorders","volume":"12","author":"Han","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.neurot.2025.e00816_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.105039","article-title":"Association of serum allopregnanolone with restricted and repetitive behaviors in adult males with autism","volume":"123","author":"Chew","year":"2021","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00816_bib17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/medicina57090893","article-title":"Neuroinflammation in autism and supplementation based on Omega-3 polyunsaturated fatty acids: a narrative review","volume":"57","author":"Veselinovi\u0107","year":"2021","journal-title":"Medicina (Mex)"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2025.e00816_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1054\/plef.2000.0186","article-title":"Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders?","volume":"63","author":"Bell","year":"2000","journal-title":"Prostaglandins Leukot Essent Fat Acids PLEFA"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00816_bib19","first-page":"21","article-title":"Observable essential fatty acid deficiency markers and autism spectrum disorder","volume":"22","author":"Brown","year":"2014","journal-title":"Breastfeed Rev Prof Publ Nurs Mothers Assoc Aust"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00816_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156432","article-title":"Omega-3 and Omega-6 polyunsaturated fatty acid levels and correlations with symptoms in children with attention deficit hyperactivity disorder, autistic spectrum disorder and typically developing controls. Lakshmana MK, curatore","volume":"11","author":"Parletta","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00816_bib21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MPG.0000000000000260","article-title":"Dietary docosahexaenoic acid supplementation in children with autism","volume":"58","author":"Voigt","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00816_bib22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.euroneuro.2015.12.031","article-title":"Effects of omega-3 polyunsaturated fatty acids on human brain morphology and function: what is the evidence?","volume":"26","author":"Bos","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00816_bib23","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3390\/nu12072090","article-title":"Perinatal docosahexaenoic acid supplementation improves cognition and alters brain functional organization in piglets","volume":"12","author":"Fang","year":"2020","journal-title":"Nutrients"},{"issue":"S3","key":"10.1016\/j.neurot.2025.e00816_bib24","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/sj.ejcn.1601478","article-title":"Polyunsaturated fatty acids, inflammation and immunity","volume":"56","author":"Calder","year":"2002","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00816_bib25","article-title":"Significance of long chain polyunsaturated fatty acids in human health","volume":"6","author":"Z\u00e1rate","year":"2017","journal-title":"Clin Transl Med [Internet]"},{"issue":"7503","key":"10.1016\/j.neurot.2025.e00816_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00816_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an Omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00816_bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jnutbio.2009.12.004","article-title":"Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids","volume":"21","author":"Adkins","year":"2010","journal-title":"J Nutr Biochem"},{"issue":"4\u20135","key":"10.1016\/j.neurot.2025.e00816_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2006.07.012","article-title":"Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls","volume":"75","author":"Nieminen","year":"2006","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00816_bib30","article-title":"Ultra-micronized palmitoylethanolamide: an efficacious adjuvant therapy for parkinson's disease","volume":"16","author":"Brotini","year":"2017","journal-title":"CNS Neurol Disord - Drug Targets [Internet]"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00816_bib31","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/nu13041346","article-title":"Palmitoylethanolamide and its biobehavioral correlates in autism spectrum disorder: a systematic review of human and animal evidence","volume":"13","author":"Colizzi","year":"2021","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00816_bib32","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1526-4637.2012.01432.x","article-title":"Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis","volume":"13","author":"Gatti","year":"2012","journal-title":"Pain Med"},{"key":"10.1016\/j.neurot.2025.e00816_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/325061","article-title":"Beneficial effects of palmitoylethanolamide on expressive language, cognition, and behaviors in autism: a report of two cases","volume":"2015","author":"Antonucci","year":"2015","journal-title":"Case Rep Psychiatry"},{"key":"10.1016\/j.neurot.2025.e00816_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1463849","article-title":"Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two cases","author":"Bortoletto","year":"2024","journal-title":"Front Psychiatry [Internet]"},{"key":"10.1016\/j.neurot.2025.e00816_bib35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbi.2018.09.003","article-title":"Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf\/J mice: contribution of central and peripheral mechanisms","volume":"74","author":"Cristiano","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurot.2025.e00816_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jpsychires.2018.04.022","article-title":"Palmitoylethanolamide as adjunctive therapy for autism: efficacy and safety results from a randomized controlled trial","volume":"103","author":"Khalaj","year":"2018","journal-title":"J Psychiatr Res"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00816_bib37","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.biopsych.2019.02.006","article-title":"Stimulation of peroxisome proliferator-activated Receptor-\u03b1 by N-Palmitoylethanolamine engages allopregnanolone biosynthesis to modulate emotional behavior","volume":"85","author":"Locci","year":"2019","journal-title":"Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00816_bib38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2826.2011.02152.x","article-title":"Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 cells and primary astrocytes: involvement of peroxisome-proliferator activated Receptor-\u03b1: pea induces allopregnanolone release in astrocyte","volume":"23","author":"Raso","year":"2011","journal-title":"J Neuroendocrinol"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2025.e00816_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","article-title":"Elevated immune response in the brain of autistic patients","volume":"207","author":"Li","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00816_bib40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.biopsych.2010.05.024","article-title":"Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism","volume":"68","author":"Morgan","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00816_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00816_bib42","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2025.e00816_bib43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fimmu.2018.00758","article-title":"NOD-like receptor protein 3 inflammasome-dependent IL-1\u03b2 accelerated ConA-Induced hepatitis","volume":"9","author":"Luan","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00816_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2009.08.001","article-title":"Differential monocyte responses to TLR ligands in children with autism spectrum disorders","volume":"24","author":"Enstrom","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurot.2025.e00816_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.freeradbiomed.2024.10.297","article-title":"NLRP3 inflammasome-mitochondrion loop in autism spectrum disorder","volume":"225","author":"Vallese","year":"2024","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00816_bib46","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1007\/s12035-019-01742-2","article-title":"Oxidative stress in autism spectrum disorder","volume":"57","author":"Bj\u00f8rklund","year":"2020","journal-title":"Mol Neurobiol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00816_bib47","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1096\/fj.201902677R","article-title":"Alterations of mitochondrial bioenergetics, dynamics, and morphology support the theory of oxidative damage involvement in autism spectrum disorder","volume":"34","author":"Pecorelli","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.neurot.2025.e00816_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00816_bib49","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.neuroscience.2008.05.061","article-title":"Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition","volume":"155","author":"Wu","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurot.2025.e00816_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2018.05.042","article-title":"A role for peroxisome proliferator-activated receptor \u03b1 in anticonvulsant activity of docosahexaenoic acid against seizures induced by pentylenetetrazole","volume":"681","author":"Gavzan","year":"2018","journal-title":"Neurosci Lett"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00816_bib51","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.bbamem.2017.02.020","article-title":"The hydroxylated form of docosahexaenoic acid (DHA-H) modifies the brain lipid composition in a model of Alzheimer's disease, improving behavioral motor function and survival","volume":"1859","author":"Mohaibes","year":"2017","journal-title":"Biochim Biophys Acta BBA - Biomembr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00816_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.physbeh.2005.09.002","article-title":"The use of behavioral test batteries, II: effect of test interval","volume":"87","author":"Paylor","year":"2006","journal-title":"Physiol Behav"},{"key":"10.1016\/j.neurot.2025.e00816_bib53","series-title":"Progress in brain research [Internet]","first-page":"113","article-title":"Neurosteroids","author":"Reddy","year":"2010"},{"key":"10.1016\/j.neurot.2025.e00816_bib54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbr.2017.07.019","article-title":"Decrease in endogenous brain allopregnanolone induces autism spectrum disorder (ASD)-like behavior in mice: a novel animal model of ASD","volume":"334","author":"Ebihara","year":"2017","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neurot.2025.e00816_bib55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2015.11.003","article-title":"Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory\/excitatory genes in the frontal cortex of an autism model","volume":"102","author":"Kratsman","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00816_bib56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pain.2011.08.010","article-title":"Implication of allopregnanolone in the antinociceptive effect of N -palmitoylethanolamide in acute or persistent pain","volume":"153","author":"Sasso","year":"2012","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00816_bib57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.euroneuro.2009.09.003","article-title":"Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice","volume":"20","author":"Sasso","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00816_bib58","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.0801853105","article-title":"Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: a model relevant for posttraumatic stress disorder","volume":"105","author":"Pibiri","year":"2008","journal-title":"Proc Natl Acad Sci"},{"issue":"10146","key":"10.1016\/j.neurot.2025.e00816_bib59","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","article-title":"Autism spectrum disorder","volume":"392","author":"Lord","year":"2018","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00816_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910678","article-title":"PPAR-\u03b1 hypermethylation in the hippocampus of mice exposed to social isolation stress is associated with enhanced neuroinflammation and aggressive behavior","volume":"22","author":"Matrisciano","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00816_bib61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.molmet.2015.04.005","article-title":"Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice","volume":"4","author":"D'Agostino","year":"2015","journal-title":"Mol Metab"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00816_bib62","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/01.HYP.36.5.851","article-title":"Docosahexaenoic acid, a peroxisome proliferator\u2013activated Receptor-\u03b1 ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase","volume":"36","author":"Diep","year":"2000","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00816_bib63","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1194\/jlr.M034942","article-title":"DHA attenuates postprandial hyperlipidemia via activating PPAR\u03b1 in intestinal epithelial cells","volume":"54","author":"Kimura","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.neurot.2025.e00816_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110811","article-title":"Docosahexaenoic acid inhibits TNF\u03b1-induced ICAM-1 expression by activating PPAR\u03b1 and autophagy in human endothelial cells","volume":"134","author":"Lin","year":"2019","journal-title":"Food Chem Toxicol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00816_bib65","article-title":"N-3 PUFA supplementation triggers PPAR-\u03b1 activation and PPAR-\u03b1\/NF-\u03baB interaction: anti-Inflammatory implications in liver ischemia-reperfusion injury","volume":"6","author":"Z\u00fa\u00f1iga","year":"2011","journal-title":"Li J, curatore PLoS ONE"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00816_bib66","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.biopsych.2023.04.025","article-title":"Role of PPAR-allopregnanolone signaling in behavioral and inflammatory gut-brain axis communications","volume":"94","author":"Pinna","year":"2023","journal-title":"Biol Psychiatry"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00816_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101727","article-title":"PPAR\u03b1 ligand-binding domain structures with endogenous fatty acids and fibrates","volume":"23","author":"Kamata","year":"2020","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00816_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated Receptor-\u03b1 mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00816_bib69","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3390\/biomedicines13061271","article-title":"Palmitoylethanolamide: a multifunctional molecule for neuroprotection, chronic pain, and immune modulation","volume":"13","author":"Di Stefano","year":"2025","journal-title":"Biomedicines"},{"issue":"741","key":"10.1016\/j.neurot.2025.e00816_bib70","doi-asserted-by":"crossref","first-page":"eabo1857","DOI":"10.1126\/scisignal.abo1857","article-title":"The omega-3 hydroxy fatty acid 7(S)-HDHA is a high-affinity PPAR\u03b1 ligand that regulates brain neuronal morphology","volume":"15","author":"Liu","year":"2022","journal-title":"Sci Signal"},{"key":"10.1016\/j.neurot.2025.e00816_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2020.100222","article-title":"PPAR and functional foods: rationale for natural neurosteroid-based interventions for postpartum depression","volume":"12","author":"Matrisciano","year":"2020","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.neurot.2025.e00816_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/ocl\/2023030","article-title":"DHA (omega-3 fatty acid) increases the action of brain-derived neurotrophic factor (BDNF)","volume":"31","author":"Majou","year":"2024","journal-title":"OCL"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00816_bib73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2202-13-109","article-title":"Omega 3 polyunsaturated fatty acid improves spatial learning and hippocampal peroxisome proliferator activated receptors (PPAR\u03b1 and PPAR\u03b3) gene expression in rats","volume":"13","author":"Hajjar","year":"2012","journal-title":"BMC Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00816_bib74","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/2053369119875386","article-title":"There is increasing evidence to suggest that brain inflammation could play a key role in the aetiology of psychiatric illness. Could inflammation be a cause of the premenstrual syndromes PMS and PMDD?","volume":"25","author":"Bannister","year":"2019","journal-title":"Post Reprod Health"},{"issue":"7612","key":"10.1016\/j.neurot.2025.e00816_bib75","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature18626","article-title":"Unexpected role of interferon-\u03b3 in regulating neuronal connectivity and social behaviour","volume":"535","author":"Filiano","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00816_bib76","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nm.4340","article-title":"CX3CR1+ monocytes modulate learning and learning-dependent dendritic spine remodeling via TNF-\u03b1","volume":"23","author":"Garr\u00e9","year":"2017","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00816_bib77","first-page":"735","article-title":"The emerging role of docosahexaenoic acid in neuroinflammation","volume":"9","author":"Orr","year":"2008","journal-title":"Curr Opin Investig Drugs Lond Engl"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00816_bib78","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cyto.2007.03.004","article-title":"Role of interleukin-1\u03b2 in the control of neuroepithelial proliferation and differentiation of the spinal cord during development","volume":"37","author":"De La Mano","year":"2007","journal-title":"Cytokine"},{"issue":"38","key":"10.1016\/j.neurot.2025.e00816_bib79","doi-asserted-by":"crossref","first-page":"13485","DOI":"10.1523\/JNEUROSCI.2136-11.2011","article-title":"IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans -Synaptic interaction with protein tyrosine phosphatase \u03b4","volume":"31","author":"Yoshida","year":"2011","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00816_bib80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-8-52","article-title":"IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation","volume":"8","author":"Wei","year":"2011","journal-title":"J Neuroinflammation"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00816_bib81","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1096\/fj.04-1625fje","article-title":"Interleukin-6: a cytokine to forget","volume":"18","author":"Balschun","year":"2004","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00816_bib82","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(95)11976-4","article-title":"Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6","volume":"198","author":"Bellinger","year":"1995","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2025.e00816_bib83","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0006-8993(96)01283-8","article-title":"Interleukin-6 inhibits long-term potentiation in rat hippocampal slices","volume":"748","author":"Li","year":"1997","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00816_bib84","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbr.2003.12.018","article-title":"Cognitive function in young and adult IL (interleukin)-6 deficient mice","volume":"153","author":"Braida","year":"2004","journal-title":"Behav Brain Res"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00816_bib85","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1046\/j.1460-9568.1998.00377.x","article-title":"Behavioural characterization of interleukin-6 overexpressing or deficient mice during agonistic encounters","volume":"10","author":"Alleva","year":"1998","journal-title":"Eur J Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2025.e00816_bib86","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0165-5728(98)00199-4","article-title":"IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6","volume":"92","author":"Armario","year":"1998","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00816_bib87","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1471-4159.2011.07481.x","article-title":"Inflammasome activation and IL-1\u03b2\/IL-18 processing are influenced by distinct pathways in microglia","volume":"119","author":"Hanamsagar","year":"2011","journal-title":"J Neurochem"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00816_bib88","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s11064-013-1122-0","article-title":"Possible role of oxidative stress and brain derived neurotrophic factor in Triazophos induced cognitive impairment in rats","volume":"38","author":"Jain","year":"2013","journal-title":"Neurochem Res"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00816_bib89","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12640-013-9393-4","article-title":"Altered cytokine and BDNF levels in autism spectrum disorder","volume":"24","author":"Ricci","year":"2013","journal-title":"Neurotox Res"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00816_bib90","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejpn.2015.03.005","article-title":"Brain derived neurotrophic factor (BDNF) and autism spectrum disorders (ASD) in childhood","volume":"19","author":"Bryn","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00816_bib91","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/07388551.2016.1207153","article-title":"Docosahexaenoic acid: one molecule diverse functions","volume":"37","author":"Hashimoto","year":"2017","journal-title":"Crit Rev Biotechnol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00816_bib92","article-title":"Brain-derived neurotrophic factor in children with autism spectrum disorder","volume":"21","author":"Kasarpalkar","year":"2014","journal-title":"Ann Neurosci [Internet]"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00816_bib93","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijdevneu.2007.07.002","article-title":"Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls","volume":"25","author":"Katoh-Semba","year":"2007","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.neurot.2025.e00816_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2015.00324","article-title":"Hippocampal transcriptomic and proteomic alterations in the BTBR mouse model of autism spectrum disorder","author":"Daimon","year":"2015","journal-title":"Front Physiol [Internet]"},{"key":"10.1016\/j.neurot.2025.e00816_bib95","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbr.2012.12.028","article-title":"Reduced social interaction, behavioural flexibility and BDNF signalling in the BTBR T+tf\/J strain, a mouse model of autism","volume":"251","author":"Scattoni","year":"2013","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00816_bib96","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2040-2392-2-7","article-title":"Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis","volume":"2","author":"Stephenson","year":"2011","journal-title":"Mol Autism"},{"key":"10.1016\/j.neurot.2025.e00816_bib97","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nbd.2014.09.014","article-title":"Interactive actions of Bdnf methylation and cell metabolism for building neural resilience under the influence of diet","volume":"73","author":"Tyagi","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00816_bib98","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41386-020-0656-5","article-title":"Targeting inhibitory cerebellar circuitry to alleviate behavioral deficits in a mouse model for studying idiopathic autism","volume":"45","author":"Chao","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00816_bib99","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator\u2013activated receptor agonists","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00816_bib100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40001-025-02424-7","article-title":"Resolvin D1 accelerates resolution of neuroinflammation by inhibiting microglia activation through the BDNF\/TrkB signaling pathway","volume":"30","author":"Bo","year":"2025","journal-title":"Eur J Med Res"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00816_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910672","article-title":"Phospholipids, sphingolipids, and cholesterol-derived lipid mediators and their role in neurological disorders","volume":"25","author":"Farooqui","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00816_bib102","article-title":"Research trends of inflammation in autism spectrum disorders: a bibliometric analysis","author":"Chen","year":"2025","journal-title":"Front Immunol [Internet]"},{"key":"10.1016\/j.neurot.2025.e00816_bib103","first-page":"1","article-title":"Impact of omega-3 fatty acid supplementation on clinical manifestations in autism spectrum disorders: an umbrella review of meta-analyses","author":"Abbasi","year":"2024","journal-title":"Nutr Res Rev"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00816_bib104","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1007\/s10803-021-05396-9","article-title":"Randomized controlled trial of Omega-3 and -6 fatty acid supplementation to reduce inflammatory markers in children with autism spectrum disorder","volume":"52","author":"Keim","year":"2022","journal-title":"J Autism Dev Disord"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:06:47Z","timestamp":1775189207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1878747925002946"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00816","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose combination of ultramicronized palmitoylethanolamide and docosahexaenoic acid on neurosteroid and neuroinflammatory dysregulation in autism spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00816"}}